Natraj Proteins Ltd

Natraj Proteins Ltd

$NATRAJPREdible OilBSE

Natraj Proteins Ltd (NATRAJPR) last traded at ₹40.4, a market capitalisation of ₹15.2 crore, on a P/E of 3.40. Over the past 52 weeks the stock has ranged between ₹28 and ₹46.4. Natraj Proteins Ltd last reported results for the quarter ended Jun 2026, with sales of ₹31.42 crore and net profit of ₹2.11 crore. The next scheduled event is an other on 1 Oct 2026. Figures are as of 25 Aug 2026 and are not real time.

Natraj Proteins Ltd share price and key metrics

Current price
₹40.4
Market cap
₹15.2 cr
Stock P/E
3.40
Book value
₹89
ROE
3.48%
ROCE
5.63%
Dividend yield
0.00%
52w high / low
46.4/28.0

Metrics as of 25 Aug 2026. Not real time.

Natraj Proteins Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹31.42 cr, up 18.3% from ₹26.56 cr a year earlier. Net profit turned positive at ₹2.11 cr.

Natraj Proteins Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales22.7933.4123.0626.5626.9228.7718.8731.42
Expenses23.1932.7821.1927.1927.9425.2317.1528.61
Operating profit-0.40.631.87-0.63-1.023.541.722.81
OPM %-1.76%1.89%8.11%-2.37%-3.79%12.30%9.11%8.94%
Other income0.060.020.350.070.050.040.10.05
Interest0.550.50.660.550.580.590.660.63
Depreciation0.090.10.070.090.090.090.110.11
Profit before tax-0.980.051.49-1.2-1.642.91.052.12
Tax %4.08%40.00%15.44%0.83%0.61%0.34%-5.71%0.47%
Net profit-1.010.031.26-1.21-1.652.891.112.11
EPS (₹)-2.700.083.36-3.23-4.407.712.965.63

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Natraj Proteins Ltd annual results

Natraj Proteins Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales146145144194118101106
Operating profit3143-9147
OPM %2.1%10%2.2%-4.8%0.9%3.6%7%
Net profit091-13-114
EPS (₹)1.0424.981.89-33.41-3.903.0411.90

TTM is the trailing twelve months to the most recent quarter.

Natraj Proteins Ltd growth and returns

Compounded Sales Growth
10 Years
-7%
5 Years
-7%
3 Years
-11%
TTM
0%
Compounded Profit Growth
10 Years
8%
5 Years
24%
3 Years
17%
TTM
580%
Stock Price CAGR
10 Years
3%
5 Years
-15%
3 Years
-4%
1 Year
1%
Return on Equity
10 Years
0%
5 Years
-1%
3 Years
-12%
Last Year
3%

Natraj Proteins Ltd shareholding pattern

Promoters held 41.82% at Jun 2026, broadly unchanged since Jun 2025. DIIs 1.90%.

Natraj Proteins Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters42.63%42.23%42.16%42.16%42.14%41.82%41.82%41.82%
DIIs1.93%1.93%1.93%1.93%1.93%1.93%1.90%1.90%
Public55.43%55.85%55.91%55.91%55.93%56.25%56.29%56.28%
No. of shareholders2,9112,9963,0653,0643,1403,1633,1943,099

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Natraj Proteins Ltd events

The next scheduled event is an other on 1 Oct 2026.

  • OtherRe-appointment of Shri Sharad Kumar Jain as Whole Time Director

See the full results calendar for every Indian company reporting in the next 30 days.

Natraj Proteins Ltd corporate filings

  • Submission of newspaper advertisement publication related to extract of quarterly Un-audited financial results of the company for the quarter ended 30th June, 2026.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited reported a robust performance for the quarter ended 30th June…

    Read the full analysis
  • Re-appointment of Shri Sharad Kumar Jain (DIN: 02757935) as the Whole Time Director of the Company for a further period of 3 years w.e.f. 1st October, 2026 subject to approval of members ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited has formally announced the re-appointment of Shri Sharad Kumar…

    Read the full analysis
  • Appointment of the Cost Auditor of the Company for the Financial Year 2026-27.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited has formally announced the appointment of M/s Yogesh Chourasia…

    Read the full analysis
  • We are pleased to submit the Un-audited financial results along with limited review report for the Quarter ended 30th June,2026.Resulthigh impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited has reported a significant financial turnaround for the quarter…

    Read the full analysis
  • We are pleased to submit the outcome of 03/2026-27 meeting of Board of Directors held on 13th August,2026 as per Regulation 30 of SEBI (LODR) Regulation, 2015 for approval of Un-audited ....Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited has reported a significant financial turnaround for the quarter…

    Read the full analysis
  • Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the following businesses: 1. ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Natraj Proteins Limited has issued a formal intimation regarding a Board Meeting…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Natraj Proteins Ltd

Cruxal reads every Natraj Proteins Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Natraj Proteins Ltd (NATRAJPR) Results, Financials & Share Price | Cruxal